These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37739899)

  • 1. Limited benefits from no-touch radiofrequency ablation in small hepatocellular carcinoma: Systematic review with meta-analysis.
    Zhang L; Du F; Ren L
    Asian J Surg; 2023 Dec; 46(12):5926-5927. PubMed ID: 37739899
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates.
    Teng YX; Zhang WG; Chan AW; Chong CCN; Serenari M; Wang YY; Peng N; Huang T; Lu SD; Liang ZY; Ma L; Zhong JH
    Aliment Pharmacol Ther; 2023 Apr; 57(7):810-812. PubMed ID: 36913504
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates - authors' reply.
    Tong Y; Chang DH; Xiao YD
    Aliment Pharmacol Ther; 2023 Apr; 57(7):813-814. PubMed ID: 36913502
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical resection versus radiofrequency ablation for the curative treatment of intrahepatic recurrent hepatocellular carcinoma: an unsolved question.
    Zizzo M; Sanguedolce F; Palicelli A; Ascani S; Zanelli M
    HPB (Oxford); 2022 Jun; 24(6):994-995. PubMed ID: 34980575
    [No Abstract]   [Full Text] [Related]  

  • 5. Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
    Kim TH; Lee JM; Lee DH; Joo I; Park SJ; Yoon JH
    Eur Radiol; 2023 Jan; 33(1):545-554. PubMed ID: 35907024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of trans-hepatic artery chemoembolization combined with radiofrequency ablation versus transhepatic artery chemoembolization alone for recurrent liver cancer after hepatectomy.
    Ji B; Hao F; Wu X; Lu Z
    Asian J Surg; 2023 Apr; 46(4):1819-1821. PubMed ID: 36504155
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis.
    Jin S; Tan S; Peng W; Jiang Y; Luo C
    World J Surg Oncol; 2020 Aug; 18(1):199. PubMed ID: 32787883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma.
    Duan L; Zhang BH; Zheng XH
    Radiology; 2022 May; 303(2):E27. PubMed ID: 35230184
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the Editor: Is eliminating METTL1-mediated accumulation of PMN-MDSCs sufficient to prevent hepatocellular carcinoma recurrence after radiofrequency ablation?
    Yang F; Jiang S; Zheng Y
    Hepatology; 2023 Apr; 77(4):E62-E63. PubMed ID: 35753066
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection].
    Ren ZG; Gan YH; Fan J; Chen Y; Wu ZQ; Qin LX; Ge NL; Zhou J; Xia JL; Wang YH; Ye QH; Wang L; Ye SL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1614-6. PubMed ID: 19094752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to Erridge et al. 'Re: Gavriilidis et al., 'Survival following Redo Hepatectomy vs Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis''.
    Gavriilidis P; Askari A; Azoulay D
    HPB (Oxford); 2017 Sep; 19(9):832-833. PubMed ID: 28709725
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival outcome of salvage hepatectomy in patients with local, recurrent hepatocellular carcinoma who underwent radiofrequency ablation as their first treatment.
    Ueno M; Nakai T; Hayashi M; Hirokawa F; Nagano H; Wada H; Kaibori M; Matsui K; Tanaka S; Yamaue H; Kubo S
    Surgery; 2016 Sep; 160(3):661-70. PubMed ID: 27267547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
    Yang Y; Yu H; Tan X; You Y; Liu F; Zhao T; Qi J; Li J; Feng Y; Zhu Q
    Int J Hyperthermia; 2021; 38(1):875-886. PubMed ID: 34078221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A well-matched marriage of immunotherapy and radiofrequency ablation to reduce the relapse and progression of hepatocellular carcinoma.
    Liao R; Song P; Duan Y; Ye W; Yin K; Kang M; Yu Y; Yang J; Tang W
    Biosci Trends; 2022 Nov; 16(5):377-380. PubMed ID: 36089338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Lee DH; Lee MW; Kim PN; Lee YJ; Park HS; Lee JM
    Radiology; 2021 Oct; 301(1):229-236. PubMed ID: 34313474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma.
    Chai B; Wang W; Wang F; Zhou G; Zheng C
    Int J Hyperthermia; 2021; 38(1):1685-1694. PubMed ID: 34843653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The successful treatment for cardiac tamponade during radiofrequency ablation of hepatocellular carcinoma.
    Xue C; Ren Z; Hu X; He Y; Sun R; Li J; Cui G; Yu Z
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):90-92. PubMed ID: 30579735
    [No Abstract]   [Full Text] [Related]  

  • 19. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the use of microwave ablation more effective and/or safe that radiofrequency ablation in the treatment of hepatocellular carcinoma?
    Anzai A; Utino A; Katayama H; Spir IAZ; Lemos MA; Nery MM; Anhesini M; Tiezzi OS; Spir PRN; Otani P; Bernardo WM
    Rev Assoc Med Bras (1992); 2020 Apr; 66(4):392-399. PubMed ID: 32578767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.